HighGravityDataHologic — Nov 4, 2024 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001140361-24-045107
Showing in the filing
Revenue Organic excluding COVID-19 % Increase (Decrease)
“3.4% to 4.7%”
Period
FY2025
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 24
Accelerated share repurchase (ASR) agreement for Q1 FY2025
“$250 million”
Anticipated closing of Gynesonics acquisition for FY2025
“first half of calendar year 2025”
Non-GAAP tax rate ( basis) for FY2025
“approximately 19.5%”
Non-GAAP tax rate for FY2024
“approximately 19.5%”
Diluted shares outstanding ( basis) for FY2025
“approximately 235 million”
Diluted shares outstanding for FY2024
“approximately 235 million”
Revenue for FY2025
“$4,150 - $4,200”
Revenue Reported % Increase (Decrease) for FY2025
“3.0% to 4.2%”
Revenue Constant Currency % Increase (Decrea… for FY2025
“2.3% to 3.5%”
Revenue Organic % Increase (Decrease) for FY2025
“1.7% to 3.0%”
Revenue Organic excluding COVID-19 % Increas… for FY2025
“3.4% to 4.7%”
GAAP EPS for FY2025
“$3.53 - $3.63”
GAAP EPS Reported % Increase (Decrease) for FY2025
“6.3% to 9.3%”
Non-GAAP EPS for FY2025
“$4.25 - $4.35”
Non-GAAP EPS Reported % Increase (Decrease) for FY2025
“4.2% to 6.6%”
Revenue for Q1 FY2025
“$1,025 - $1,035”
Revenue Reported % Increase (Decrease) for Q1 FY2025
“1.2% to 2.2%”
Revenue Constant Currency % Increase (Decrea… for Q1 FY2025
“0.4% to 1.4%”
Revenue Organic % Increase (Decrease) for Q1 FY2025
“(0.2%) to 0.8%”
Revenue Organic excluding COVID-19 % Increas… for Q1 FY2025
“1.8% to 2.8%”
GAAP EPS for Q1 FY2025
“$0.81 - $0.84”
GAAP EPS Reported % Increase (Decrease) for Q1 FY2025
“(21.4%) to (18.4%)”
Non-GAAP EPS for Q1 FY2025
“$1.00 - $1.03”
Non-GAAP EPS Reported % Increase (Decrease) for Q1 FY2025
“2.0% to 5.1%”
Exhibit 99.1 · the passage around this item
… earlier in the release
Current Guidance
Guidance $
Reported %
Increase
(Decrease)
Constant Currency
% Increase
(Decrease)
Organic % Increase
(Decrease)
Organic excluding
COVID-19 % Increase
(Decrease)
Fiscal 2025
Revenue
$4,150 - $4,200
3.0% to 4.2%
2.3% to 3.5%
1.7% to 3.0%
3.4% to 4.7%
GAAP EPS
$3.53 - $3.63
6.3% to 9.3%
Non-GAAP EPS
$4.25 - $4.35
4.2% to 6.6%
Q1 2025
Revenue
$1,025 - $1,035
1.2% to 2.2%
0.4% to 1.4%
(0.2%) to 0.8%
1.8% to 2.8%
GAAP EPS
$0.81 - $0.84
(21.4%) to (18.4%)
Non-GAAP EPS
$1.00 - $1.03
2.0% to 5.1%
3
Use of Non-GAAP Financial Measures
The Company has presented the following non-GAAP financial measures in this press release: constant currency revenues; organic revenues; organic revenues excluding
COVID-19; non-GAAP gross margin; non-GAAP operating expenses; non-GAAP operating margin; non-GAAP effective tax rate; non-GAAP net income; non-GAAP net income margin; non-GAAP EPS; adjusted EBITDA; adjusted net leverage ratio and adjusted ROIC.
Organic revenue for the fiscal fourth quarter of 2024 e
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.